Understanding the different causes of Alzheimer's disease
Discovering Heterogeneous Causal Pathophysiology of Alzheimer's Disease
This study is looking into how Alzheimer's disease affects different groups of people and aims to find the best ways to treat it by understanding the roles of certain proteins in the brain, so that future treatments can be more personalized and effective for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11135114 on NIH RePORTER |
What this research studies
This research investigates the complex causes of Alzheimer's disease (AD) by analyzing existing data to identify how different subpopulations are affected by the disease. The team will develop new statistical methods to uncover the relationships between Amyloid-beta and tau proteins and their impact on cognitive function. By understanding these relationships, the research aims to determine the best timing and target groups for treatments that lower these proteins. This approach could lead to more effective treatment strategies tailored to individual patient needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, particularly those who may respond differently to current treatments based on their unique biological profiles.
Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for Alzheimer's disease, improving cognitive outcomes for patients.
How similar studies have performed: Previous research has shown promise in understanding Alzheimer's disease through similar statistical approaches, indicating potential for success in this novel investigation.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Wang, Jingshen — University of California Berkeley
- Study coordinator: Wang, Jingshen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.